Josée Golay

11.6k total citations
140 papers, 8.8k citations indexed

About

Josée Golay is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, Josée Golay has authored 140 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Immunology, 54 papers in Genetics and 46 papers in Molecular Biology. Recurrent topics in Josée Golay's work include Chronic Lymphocytic Leukemia Research (37 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Immune Cell Function and Interaction (28 papers). Josée Golay is often cited by papers focused on Chronic Lymphocytic Leukemia Research (37 papers), Monoclonal and Polyclonal Antibodies Research (35 papers) and Immune Cell Function and Interaction (28 papers). Josée Golay collaborates with scholars based in Italy, United States and United Kingdom. Josée Golay's co-authors include Martino Introna, Alessandro Rambaldi, Gianmaria Borleri, Alberto Mantovani, Sergio Bernasconi, Guillaume Cartron, Philippe Solal‐Céligny, Hervé Watier, Tiziano Barbui and Nicola Di Gaetano and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Josée Golay

139 papers receiving 8.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josée Golay Italy 52 4.2k 2.8k 2.5k 2.2k 2.0k 140 8.8k
Roland Schwarting United States 40 3.2k 0.8× 1.4k 0.5× 2.2k 0.9× 1.1k 0.5× 1.0k 0.5× 96 8.0k
Sattva S. Neelapu United States 50 4.3k 1.0× 3.3k 1.2× 8.8k 3.5× 1.5k 0.7× 644 0.3× 418 13.4k
Paschalis Sideras Sweden 40 4.8k 1.2× 1.8k 0.7× 837 0.3× 1.5k 0.7× 562 0.3× 79 7.3k
Gerhard Moldenhauer Germany 52 2.9k 0.7× 3.4k 1.2× 2.7k 1.1× 501 0.2× 1.8k 0.9× 129 7.6k
Elisabeth Ralfkiær Denmark 58 2.3k 0.5× 2.7k 1.0× 3.9k 1.5× 1.4k 0.6× 421 0.2× 199 10.2k
Qing Yi United States 54 4.9k 1.2× 3.8k 1.4× 3.6k 1.4× 590 0.3× 478 0.2× 197 9.8k
Tuna Mutis Netherlands 50 4.7k 1.1× 2.7k 1.0× 4.1k 1.6× 822 0.4× 1.2k 0.6× 180 9.4k
Martine Amiot France 49 1.8k 0.4× 4.8k 1.7× 2.7k 1.1× 799 0.4× 603 0.3× 131 7.9k
Marc Schmitz Germany 46 3.2k 0.8× 2.0k 0.7× 2.8k 1.1× 851 0.4× 477 0.2× 173 6.4k
Elena Sabattini Italy 40 1.5k 0.4× 1.3k 0.5× 2.8k 1.1× 1.5k 0.7× 396 0.2× 221 6.6k

Countries citing papers authored by Josée Golay

Since Specialization
Citations

This map shows the geographic impact of Josée Golay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josée Golay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josée Golay more than expected).

Fields of papers citing papers by Josée Golay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josée Golay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josée Golay. The network helps show where Josée Golay may publish in the future.

Co-authorship network of co-authors of Josée Golay

This figure shows the co-authorship network connecting the top 25 collaborators of Josée Golay. A scholar is included among the top collaborators of Josée Golay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josée Golay. Josée Golay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tettamanti, Sarah, Andrea Doni, Francesca D’Autilia, et al.. (2024). Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab. Antibodies. 13(3). 71–71. 3 indexed citations
2.
Cattaneo, Irene, Rut Valgardsdottir, Muriel Roth, et al.. (2024). Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1. Antibodies. 13(1). 15–15. 1 indexed citations
3.
Cattaneo, Irene, Rut Valgardsdottir, Roberta Cavagna, et al.. (2023). Genetic defects of gamma‐secretase genes in a multiple myeloma patient with high and dysregulated BCMA surface density: A case report. British Journal of Haematology. 204(2). 571–575. 3 indexed citations
4.
Borleri, Gianmaria, Chiara Pavoni, Giuseppe Gaipa, et al.. (2023). Optimization and validation of in vivo flow cytometry chimeric antigen receptor T cell detection method using CD19his indirect staining. Cytometry Part A. 105(2). 112–123. 3 indexed citations
5.
Capelli, Chiara, Chiara Pavoni, Simona Frigerio, et al.. (2023). Potency assays and biomarkers for cell-based advanced therapy medicinal products. Frontiers in Immunology. 14. 1186224–1186224. 19 indexed citations
6.
Capelli, Chiara, Simona Frigerio, Daniela Lisini, et al.. (2022). A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies. Cytotherapy. 24(5). 544–556. 9 indexed citations
7.
Valgardsdottir, Rut, Irene Cattaneo, Annibale Raglio, et al.. (2021). Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization. Antibodies. 10(3). 26–26. 2 indexed citations
8.
9.
Golay, Josée & Ronald P. Taylor. (2020). The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs. SHILAP Revista de lepidopterología. 9(4). 58–58. 63 indexed citations
10.
Golay, Josée, et al.. (2020). Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies. SHILAP Revista de lepidopterología. 9(2). 17–17. 20 indexed citations
11.
Golay, Josée, et al.. (2019). Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation. Blood. 133(13). 1395–1405. 42 indexed citations
12.
Golay, Josée, Rachele Alzani, Clara Albanese, et al.. (2018). Cord blood–derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors. Cytotherapy. 20(8). 1077–1088. 14 indexed citations
13.
Golay, Josée, Olga Pedrini, Chiara Capelli, et al.. (2017). Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance. Cytotherapy. 20(2). 262–270. 15 indexed citations
14.
Valgardsdottir, Rut, Irene Cattaneo, Christian Klein, et al.. (2017). Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies. Blood. 129(19). 2636–2644. 80 indexed citations
15.
Boross, Péter, J.H. Marco Jansen, Simone de Haij, et al.. (2011). The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden. Haematologica. 96(12). 1822–1830. 55 indexed citations
16.
Leidi, Marzia, Elisa Gotti, Luca Bologna, et al.. (2009). M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro. The Journal of Immunology. 182(7). 4415–4422. 220 indexed citations
17.
Gaetano, Nicola Di, Annunciata Vecchi, Valeria Grieco, et al.. (2003). Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo. The Journal of Immunology. 171(3). 1581–1587. 417 indexed citations
18.
Bonamino, Martín, Marta Serafini, Giovanna D’Amico, et al.. (2003). Functional transfer of CD40L gene in human B-cell precursor ALL blasts by second-generation SIN lentivectors. Gene Therapy. 11(1). 85–93. 14 indexed citations
19.
Luchetti, Michele Maria, Paolo Paroncini, Jon Frampton, et al.. (2003). Characterization of the c-Myb-responsive Region and Regulation of the Human Type I Collagen α2 Chain Gene by c-Myb. Journal of Biological Chemistry. 278(3). 1533–1541. 15 indexed citations
20.
Introna, Martino, Anna Maria Barbui, Chiara Casati, et al.. (2000). Genetic Modification of Human T Cells with CD20: A Strategy to Purify and Lyse Transduced Cells with Anti-CD20 Antibodies. Human Gene Therapy. 11(4). 611–620. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roland Schwarting Breakdown of academic impact, for papers by Sattva S. Neelapu Breakdown of academic impact, for papers by Paschalis Sideras Breakdown of academic impact, for papers by Gerhard Moldenhauer Breakdown of academic impact, for papers by Elisabeth Ralfkiær Breakdown of academic impact, for papers by Qing Yi Breakdown of academic impact, for papers by Tuna Mutis Breakdown of academic impact, for papers by Martine Amiot Breakdown of academic impact, for papers by Marc Schmitz Breakdown of academic impact, for papers by Elena Sabattini
Rankless by CCL
2026